The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Expression and prognostic significance of PDGF ligands (A, B, C, and D) and PDGFR (A, B, and L) in soft-tissue sarcomas and GIST.
 
Tom Lesluyes
No Relationships to Disclose
 
Jean-Yves Blay
Consulting or Advisory Role - Lilly
Research Funding - Lilly (Inst)
 
Patrick Schoffski
Honoraria - Daiichi Sankyo; Eisai; Lilly; Medscape; Novartis; Swedish Orphan Biovitrum
Consulting or Advisory Role - Adaptimmune (Inst); Amcure (Inst); AstraZeneca (Inst); Bayer (Inst); Blueprint Genetics (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Cristal Therapeutics (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Epizyme (Inst); Genzyme (Inst); Ipsen (Inst); Lilly (Inst); Loxo (Inst); Medpace (Inst); Nektar (Inst); Novartis (Inst); Philogen (Inst); Piqur (Inst)
Speakers' Bureau - Bayer; Eisai; GlaxoSmithKline; Lilly; Novartis; PharmaMar; Swedish Orphan Biovitrum
Research Funding - Bayer (Inst); Blueprint Genetics (Inst); CoBioRes NV (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Adaptimmune; Amcure; AstraZeneca; Bayer; Blueprint Genetics; Boehringer Ingelheim; Bristol-Myers Squibb; Cristal Therapeutics; Daiichi Sankyo; Eisai; Epizyme; Genzyme; Ipsen; Lilly; Loxo; Medpace; Nektar; Novartis; Philogen; Piqur
 
Antoine Italiano
No Relationships to Disclose
 
Axel Le Cesne
Consulting or Advisory Role - Lilly
Research Funding - Lilly (Inst)
 
Maria Debiec-Rychter
No Relationships to Disclose
 
Olivier Mir
No Relationships to Disclose
 
Raf Sciot
No Relationships to Disclose
 
Maud Toulmonde
No Relationships to Disclose
 
Isabelle Laure Ray-Coquard
Honoraria - AstraZeneca; PharmaMar; Roche
Consulting or Advisory Role - Abbvie; Amgen; Pfizer
 
Maria Rios
No Relationships to Disclose
 
Mehdi Brahmi
No Relationships to Disclose
 
Christine Chevreau
No Relationships to Disclose
 
Nicolas Isambert
No Relationships to Disclose
 
Sylvie Bonvalot
No Relationships to Disclose
 
Sophie Piperno-Neumann
No Relationships to Disclose
 
Jean-Michel Coindre
No Relationships to Disclose
 
Frederic Chibon
No Relationships to Disclose